Johannes Landskron, Head of the Chemical Biology Platform at NCMM, shares some insight into how the platform works, and why it is so important for…

Jing Tang joined FIMM as a senior researcher in Tero Aittokallio’s group in 2012. Here he shares some background on his career and research to date.

An international research team involving scientists from FIMM has found the first common genetic risk variants for autism.

Professor Janna Saarela officially started as Director of NCMM in January 2019. She joins NCMM from the Nordic EMBL's Finnish partner, FIMM. Here she…

GSK and Sanofi have joined the FinnGen study, a large public-private partnership aiming to collect and analyse genome and health data from 500 000…

Cryo-electron microscopy, or cryo-EM, has been around since the 1970s, but it’s only in recent years that, thanks to technological advances, the…

Professor Daly joined FIMM from the Broad Institute of MIT and Harvard and Massachusetts General Hospital. Here he discusses his research and the…

The EMBL Director General, who steps down from his role at the end of 2018, has been named as the Director of Human Technopole

In the 'Behind the Scenes' series, we will look in-depth at a researcher, or a facility, within the Nordic EMBL Partnership. In our first article, we…

Oliver Billker joined MIMS as Director in October 2018. He was previously a senior group leader at the Wellcome Trust Sanger Institute and one of the…